Blood Pressure and Metabolic Changes After 3-Month CPAP Therapy in a Very Elderly Obese with Severe Obstructive Sleep Apnea: A Case Report and Review of the Literature.
Francesco SpannellaFederico GiuliettiChiara Di PentimaFrancesca Elena LombardiElisabetta BorioniRiccardo SarzaniPublished in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2017)
Age is one of the main risk factor for the presence of obstructive sleep apnea (OSA). This syndrome is associated with hypertension, cardiovascular disease, cognitive impairment and metabolic abnormalities, such as type 2 diabetes. Continuous positive airway pressure (CPAP) represents the gold standard therapy, but its benefit is still to be determined in very elderly. We report the blood pressure and metabolic changes in a very elderly obese with severe OSA after 3-month CPAP therapy. We have evaluated a very elderly obese male affected by severe symptomatic OSA, poor controlled nocturnal hypertension and insulin resistance. After 3-month CPAP therapy, without any changes in drug therapy, we observed a normalization of circadian blood pressure (BP) pattern, an improved insulin sensitivity, together with a reduced resting energy expenditure, despite no significant change in weight. This case report shows the benefits of OSA treatment with CPAP, not only on BP profile, but also on metabolic parameters in a very elderly, a particular type of patient in which scientific evidence is still scant. Further studies are needed to better investigate the relationship between OSA, CPAP therapy and energy expenditure not only in adults but also in elderly patients.
Keyphrases
- obstructive sleep apnea
- positive airway pressure
- blood pressure
- sleep apnea
- type diabetes
- case report
- cardiovascular disease
- adipose tissue
- heart rate
- insulin resistance
- weight loss
- metabolic syndrome
- community dwelling
- hypertensive patients
- bariatric surgery
- coronary artery disease
- physical activity
- emergency department
- depressive symptoms
- heart rate variability
- mesenchymal stem cells
- blood glucose
- skeletal muscle
- cell therapy
- obese patients
- silver nanoparticles